|本期目录/Table of Contents|

[1]许静,陈炜,张鸿,等.医院获得性肺炎的治疗及预防进展[J].中华肺部疾病杂志,2022,(01):123-126.[doi:10.3877/cma.j.issn.1674-6902.2022.01.037]
点击复制

医院获得性肺炎的治疗及预防进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2022年01期
页码:
123-126
栏目:
综述
出版日期:
2022-02-20

文章信息/Info

Title:
-
作者:
许静1; 陈炜1; 张鸿1; 冯欢2
400037 重庆,陆军(第三)军医大学第二附属医院感染控制科1、泌尿外科2
Author(s):
-
关键词:
医院获得性肺炎;  治疗;  预防
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2022.01.037
摘要:
-
Abstract:
-

参考文献/References:

1 张玉江, 张 巧, 任之栋, 等. PSI、APACHEⅡ和SOFA三种评分对医院获得性肺炎预后的评估价值[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 285-288.
2 邹燕子, 陈茂刚, 朱明训, 等. 呼吸机相关肺炎患者病原菌分布、炎症指标及耐药性分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(4): 492-495.
3 Min JY, Kim HJ, Chungsik Y, et al. Hospital-acquired pneumonia among inpatients via the emergency department: A propensity-score matched analysis[J]. Int J Environ Res Public Health, 2018, 15(6): 1178.
4 Nieves S, Eva H, Irma C, et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study[J]. Am J Infect Control, 2014, 42(1): 38-42.
5 Ebru CE, Osman NH, Ilker Y, et al. Hospital-acquired pneumonia developed in non-intensive care units[J]. Respiration, 2009, 78(4): 416-422.
6 Nieves S, Miquel S, Neunos 2000 Study Group. Multicenter study of hospital-acquired pneumonia in non-ICU patients[J]. Chest, 2005, 127(1): 213-219.
7 于翠香, 王西艳. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)解读[J]. 中国医刊, 2021, 56(9): 951-953.
8 吴 凡, 赵淑好, 韩秋凤, 等. 我院神经科医院获得性肺炎237例危险因素分析[J]. 福建医药杂志, 2017, 39(4): 150-152.
9 Mateu C, Mateu SP, Elisabet P, et al. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia[J]. Age Ageing, 2010,39(1): 39-45.
10 冯 荃. 心胸外科疾病患者手术后医院获得性肺炎发生状况及其危险因素分析[J]. 国际护理学杂志, 2021, 40(23): 4248-4251.
11 American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia[J]. Am J Respir Crit Care Med, 2005, 171(4): 388-416.
12 Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia[J]. Am J Respir Crit Care Med, 2006, 173(12): 1348-1355.
13 Ofelia CT, Larry JA, Richard B, et al. Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee[J]. Respir Care, 2004, 49(8): 926-939.
14 Eric Verin, Pere Clavé, Maria Rosaria Bonsignore, et al. Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases[J]. Eur Respir J, 2017, 49(4): 1602530.
15 Ignacio Martin-Loeches, Antonio Torres, Mariano Rinaudo, et al. Resistance patterns and outcomes in intensive care unit(ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control(ECDC)and the Centers for Disease Control and Prevention(CDC)classification of multidrug resistant organisms[J]. J Infect, 2015, 70(3): 213-222.
16 Ortega O, Sakwinska O, Combremont S, et al. High prevalence of colonization of oral cavity by respiratory pathogens in frail older patients with oropharyngeal dysphagia[J]. Neurogastroenterol Motil, 2015, 27(12): 1804-1816.
17 Zhou SA, Anders B. Development of phase-contrast X-ray imaging techniques and potential medical applications[J]. Phys Med, 2008, 24(3): 129-148.
18 Naomi P O'G, Patrick RM, Nancy AA. Preventing ventilator-associated pneumonia: does the evidence support the practice[J] Jama, 2012, 307(23): 2534-2539.
19 Ignacio ML, Alejandro HR, Antoni T. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe[J]. Curr Opin Crit Care, 2018, 24(5): 347-352.
20 Solé Violán J, Fernández JA, Benítez AB, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia[J]. Crit Care Med, 2000, 28(8): 2737-2741.
21 Anita RM, Christopher SK. Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention[J]. Cleve Clin J Med, 2020,87(10): 633-639.
22 Andre CK, Mark LM, Michael K, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the american thoracic society[J]. Clin Infect Dis, 2016, 63(5): e61-e111.
23 Antoni T, Nelson L, Catia C, et al. Laboratory diagnosis of pneumonia in the molecular age[J]. Eur Respir J, 2016, 48(6): 1764-1778.
24 Joaquin B, Vicen F, Benito A. Chemical pharmacotherapy for hospital-acquired pneumonia in the elderly[J]. Expert Opin Pharmacother, 2019, 20(4): 423-434.
25 姜友珍, 李 爽, 侯德风, 等. 降钙素原、C反应蛋白、白细胞计数联合检测在ICU医院获得性细菌性肺炎鉴别诊断中的价值[J]. 检验医学, 2016, 31(6): 453-457.
26 吕文艳, 岳喻伦, 张 琳. 血清PCT、CRP、BNP及WBC联合检测在诊断医院获得性细菌性肺炎中的应用分析[J]. 国际检验医学杂志, 2017, 38(10): 1405-1407.
27 Virve IE, Yoann P, Ljuban G, et al. Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance[J]. Curr Opin Pulm Med, 2014, 20(3): 252-258.
28 Andrew AQ, Ernesto GS, Sailaja P, et al. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study[J]. BMC Infect Dis, 2013, 13: 561.
29 Scott TM, Richard GW, Marin HK, et al. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance[J]. Crit Care, 2015, 19(1): 219.
30 John E Conte Jr, Jeffrey AG, Juliana Kipps, et al. Intrapulmonary pharmacokinetics of linezolid[J]. Antimicrob Agents Chemother, 2002, 46(5): 1475-1480.
31 William AC. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid[J]. Infect Dis Clin North Am, 2003,17(3): 479-501.
32 Nicolau DP, McNabb J, Lacy MK, et al. Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia[J]. Int J Antimicrob Agents, 2001, 17(6): 497-504.
33 Martínez JA, Cobos-Trigueros N, Soriano A, et al. Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms[J]. Antimicrob Agents Chemother, 2010, 54(9): 3590-3596.
34 Scott TM, Richard MR, Marin HK. Health care-associated pneumonia(HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus(MRSA)and Pseudomonas aeruginosa predict optimal outcome[J]. Medicine(Baltimore), 2011, 90(6): 390-395.
35 Scott TM, Emily CW, Junaid K, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis[J]. Antimicrob Agents Chemother, 2010, 54(5): 1742-1748.
36 Antoni T, Michael SN, Jean C, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia(HAP)/ventilator-associated pneumonia(VAP)of the European Respiratory Society(ERS), European Society of Intensive Care Medicine(ESICM), European Society of Clinical Microbiology and Infectious Diseases(ESCMID)and Asociación Latinoamericana del Tórax(ALAT)[J]. Eur Respir J, 2017, 50(3): 1700582.
37 Zhao TT, Wu XY, Zhang Q, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia[J]. Cochrane Database Syst Rev, 2020, 12(12): Cd008367.

备注/Memo

备注/Memo:
通信作者: 陈 炜, Email: chongqingchenwei@126.com
更新日期/Last Update: 2022-02-20